Related Experiment Video

Updated: Apr 25, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.2K

Management of hepatitis C virus and human immunodeficiency virus coinfection

C R O'neil1, C S Coffin

  • 1Department of Internal Medicine, Faculty of Medicine, University of Calgary, Calgary, Canada - cscoffin@ucalgary.ca.

Minerva Gastroenterologica E Dietologica
|September 2, 2014
PubMed

Insights

Second-generation direct-acting antivirals (DAAs) significantly improve treatment outcomes for patients coinfected with HIV and Hepatitis C virus (HCV), achieving high sustained virological response (SVR) rates with minimal side effects.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Liver disease is a significant cause of illness and death in patients with HIV and Hepatitis C virus (HCV) coinfection.
  • Previous treatments for HCV in HIV-positive patients, including interferon and first-generation direct-acting antiviral agents (DAAs), had limited efficacy and significant side effects.
  • Drug-drug interactions were a major concern with earlier treatment regimens.

Purpose of the Study:

  • To provide a comprehensive overview of the epidemiology, diagnosis, screening, and treatment of HIV/HCV coinfection.
  • To highlight the advancements in treatment outcomes with second-generation DAAs for HCV/HIV coinfected patients.
  • To focus on the application of DAAs in this challenging-to-treat patient population.

Main Methods:

  • Review of current literature on HIV/HCV coinfection and its treatment.
  • Analysis of treatment outcomes with second-generation direct-acting antiviral agents (DAAs).
  • Discussion of epidemiological trends, diagnostic approaches, and screening strategies.

Main Results:

  • Second-generation DAAs have dramatically improved sustained virological response (SVR) rates in HCV/HIV coinfected patients, exceeding 90%.
  • Treatment courses with second-generation DAAs are generally simple, short, and associated with minimal adverse effects.
  • These newer agents represent a significant advancement over interferon-based regimens and first-generation DAAs.

Conclusions:

  • Second-generation DAAs offer a highly effective and well-tolerated treatment option for HCV/HIV coinfected individuals.
  • The management of HCV in HIV-positive patients has been revolutionized, leading to better health outcomes.
  • Comprehensive management strategies including screening and updated treatment protocols are crucial for this population.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

20.3K
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.2K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
75
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
42.8K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.9K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
55
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
18
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
92